《盈利預喜》彩客化學(01986.HK)料去年淨利潤按年增長至少52.1%
彩客化學(01986.HK)公布,預期去年集團淨利潤將不少於2.2億元人民幣(下同),按年增長不低於7,540萬元或52.1%。
公司指出,該增長主要由於因市場需求增加以及疫情對停產影響降低,集團染料中間體及顏料中間體產品的銷量於報告期內增加;及集團於去年6月完成電池材料磷酸鐵生產線的升級,且逐步實現大規模生產,加上市場需求強勁,磷酸鐵產品的產量、銷量及市場價格均大幅提升,帶動集團於報告期內的收益及毛利增加。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.